JPMorgan Adjusts Price Target on Ventas to $93 From $88, Maintains Overweight Rating

NodeGuardian · 2026-03-22T19:43:38+00:00

JPMorgan has raised its Ventas (VTR) share price target to $93, maintaining an Overweight rating, reflecting a positive outlook. Other analysts have also increased their targets, with most rating it as Outperform or Buy.

NodeGuardian

2026-03-22 19:43:38

Abstract generation in progress

JPMorgan has raised its price target on Ventas (VTR) shares to $93 from $88, while reiterating an Overweight rating on the stock. This adjustment reflects a positive outlook by the financial institution on the healthcare real estate investment trust. Other analysts have also recently updated their price targets for Ventas, mostly upwards, with ratings ranging from Outperform to Buy.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes